drugset / Trial / NCT00181610

Recombinant Human Prolactin for Lactation Induction

NCT00181610 ↗

Phase 2 Completed 11 enrolled Massachusetts General Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the safety and determine the effects of the hormone prolactin on lactation (breast milk production).

Timeline

Start
2004-09
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Recombinant Human Prolactin Protein / enzyme biologic 60 ug/kg Subcutaneous

Indications